WELLMOND Trademark

Trademark Overview


On Thursday, October 21, 2021, a trademark application was filed for WELLMOND with the United States Patent and Trademark Office. The USPTO has given the WELLMOND trademark a serial number of 97086004. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 23, 2023. This trademark is owned by Wellstat Therapeutics Corporation. The WELLMOND trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for treatment in the areas of oncology, hematology, neurology, dermatology, metabolic disorders, neurometabolic disorders and mitochondrial disorders all of the foregoing goods excluding pharmaceutical preparations and substances for the treatment of depression; biological preparations for treatment in the areas of oncology, anti-virals, infectious diseases and mitochondrial disorders agents for treatment in the areas of oncology, anti-virals, infectious diseases and mitochondrial disorders

Pharmaceutical and biological research and development services
wellmond

General Information


Serial Number97086004
Word MarkWELLMOND
Filing DateThursday, October 21, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment in the areas of oncology, hematology, neurology, dermatology, metabolic disorders, neurometabolic disorders and mitochondrial disorders all of the foregoing goods excluding pharmaceutical preparations and substances for the treatment of depression; biological preparations for treatment in the areas of oncology, anti-virals, infectious diseases and mitochondrial disorders agents for treatment in the areas of oncology, anti-virals, infectious diseases and mitochondrial disorders
Pseudo MarkWELL MOND
Goods and ServicesPharmaceutical and biological research and development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWellstat Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameWellstat Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Monday, October 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 25, 2022NON-FINAL ACTION E-MAILED
Wednesday, May 25, 2022NON-FINAL ACTION WRITTEN
Monday, May 23, 2022ASSIGNED TO EXAMINER
Sunday, November 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 25, 2021NEW APPLICATION ENTERED